Structure and function of VEGF/VEGF-receptor system involved in angiogenesis

Cell Structure and Function

Volumn 26, Issue 1, 2001, Pages 25-35

  Shibuya, M ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Angiogenesis; Clinical application; Endothelial cells; Signal transduction; Tyrosine kinase receptor; VEGF

Indexed keywords

ANGIOPOIETIN; EPHRIN; IMMUNOGLOBULIN; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ASCITES FLUID ANALYSIS; ASCITES TUMOR; BLOOD VESSEL PERMEABILITY; CELL PROLIFERATION; CONTROLLED STUDY; DIABETIC RETINOPATHY; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; GENE STRUCTURE; GENE TARGETING; HUMAN; MOUSE; MULTIGENE FAMILY; NONHUMAN; PARAPROTEINEMIA; PRIORITY JOURNAL; PROTEIN DOMAIN; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SOLID TUMOR; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM;

ANIMALS; ENDOTHELIAL GROWTH FACTORS; HUMANS; LYMPHOKINES; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; STRUCTURE-ACTIVITY RELATIONSHIP; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

ANIMALIA;

EID: 0035003384     PISSN: 03867196     EISSN: None     Source Type: Journal    
DOI: 10.1247/csf.26.25     Document Type: Review

References (50)

1. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins
2. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization
3. Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factorisoforms VEGF164 and VEGF188
4. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
5. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor
6. The biology of vascular endothelial growth factor
7. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
8. SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types
9. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
10. The FLT4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor receptor
11. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice
12. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization
13. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice
14. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases
15. A requirement for neuropilin-1 in embryonic vessel formation
16. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor
17. Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors
18. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
19. Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity
20. Genomic organization of the flt-1 gene encoding for vascular endothelial growth factor (VEGF) Receptor-1 suggests an intimate evolutionary relationship between the 7-Ig and the 5-Ig tyrosine kinase receptors
21. Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth, and its inhibition by the antibody
22. Regional suppression of tumor growth by in vivo transfer of a cDNA encoding a secreted form of the extracellular domain of the flt-1 vascular endothelial growth factor receptor
23. Vascular endothelial growth factor is a secreted angiogenic mitogen
24. Differential inhibition of fluid accumulation and tumor growth in two mouse ascites tumors by an anti-vascular endothelial growth factor/permeability factor neutralizing antibody
25. Significant expression of vascular endothelial growth factor/Vascular permeability factor in mouse ascites tumors
26. A variant of nuclear localization signal of bipartite-type is required for the nuclear translocation of hypoxia inducible factors (1α, 2α and 3α)
27. Endothelial receptor tyrosine kinases involved in angiogenesis
28. A novel type of vascular endothelial growth factor: VEGF-E (NZ-7 VEGF) preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain
29. FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines
30. Mechanism of angiogenesis
31. Vascular endothelial growth factor receptor-1 (Flt-1) is a novel cell surface marker for the lineage of monocyte-macrophages in humans
32. Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor (PIGF), which is related to vascular endothelial growth factor (VEGF)
33. Cell signaling by receptor tyrosine kinases
34. Growth factor signaling by receptor tyrosine kinases
35. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF
36. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
37. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
38. Structure and function of VEGF Receptor-1 and -2
39. Role of VEGF-Flt receptor system in normal and tumor angiogenesis
40. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family
41. Structure and dual function of vascular endothelial growth factor receptor-1 (Flt-1)
42. Mapping of the sites involved in ligand-association and dissociation at the extracellular domain of vascular endothelial growth factor receptor KDR
43. Increased vascularization in mice overexpressing angiopoietin-1
44. VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells
45. The 230kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLCγ pathway and partially induces mitotic signals in NIH3T3 fibroblasts
46. Characterization of the extracellular domain in the vascular endothelial growth factor receptor-1 (Flt-1 tyrosine kinase)
47. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial growth factor
48. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells
49. Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome
50. Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor